Publisher's note: This Perspective is one of the two winning Essays of the "Reimagine biomedical research for a healthier future"Essay challenge, launched by the Health Research Alliance in partnership with PLOS. This publication is coordinated with that of the other winning Essay in PLOS Biology. The competition was intended to spark a discussion around the future of biomedical research; publication does not imply endorsement from HRA or PLOS.

An open science pathway for drug marketing authorization-Registered drug approval

Cristea I. A.;
2021

Abstract

Publisher's note: This Perspective is one of the two winning Essays of the "Reimagine biomedical research for a healthier future"Essay challenge, launched by the Health Research Alliance in partnership with PLOS. This publication is coordinated with that of the other winning Essay in PLOS Biology. The competition was intended to spark a discussion around the future of biomedical research; publication does not imply endorsement from HRA or PLOS.
2021
File in questo prodotto:
File Dimensione Formato  
journal.pmed.1003726-1.pdf

accesso aperto

Tipologia: Published (publisher's version)
Licenza: Creative commons
Dimensione 565.37 kB
Formato Adobe PDF
565.37 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3461678
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
social impact